期刊文献+

新合成磺酰脲类化合物I_4抗血小板聚集及抗血栓作用 被引量:1

Effect of I_4 on antiplatelet aggregation and antithrombosis
下载PDF
导出
摘要 目的研究新合成磺酰脲类化合物I4抗血小板聚集及抗血栓作用。方法测定I4对ADP诱导兔血小板聚集、小鼠凝血时间、大鼠颈动脉旁路血栓、大鼠血栓阻塞时间的作用。结果 I4显著抑制二磷酸腺苷(ADP)诱导的体外兔血小板聚集,延长小鼠凝血时间,降低大鼠颈动脉旁路血栓重量,明显延长电刺激诱导的大鼠颈动脉血栓形成时间。结论 I4具有显著的抗血小板聚集及抗凝血作用。 Purpose To study the effects of I4-new synthetic sulfonylurea compounds on anti-platelet aggregation and antithrombosis. Methods The effects of I4 on ADP-induced rabbit isolated platelet aggre- gation, clotting time in mice, the carotid artery bypass thrombosis, thrombotic occlusion time in rats were examined. Results The effects of I4 on antiplatelet aggregation on ADP-induced in vitro rabbit platelet were significantly inhibited, blood clotting time in mice was prolonged, weight of the rat carotid artery by- pass thrombosis was reduced, and the time of rat carotid artery thrombosis stimulated by electric was sig- nificantly prolonged. ConclusionI4 has a significant anti-platelet aggregation and antithrombotic effect.
作者 张静 于锋
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2012年第6期769-771,775,共4页 Chinese Journal of Biochemical Pharmaceutics
关键词 磺酰脲类 I4 血小板聚集 血栓 sulfonylureas I4 platelet aggregation thrombosis
  • 相关文献

参考文献13

  • 1Morel 0, Kessler L, Ohlmann P, et al. Diabetes and the platelet : Toward new therapeutic paradigms for diabetic atherothrombosis[J]. Atheroselerosis ,2010,2 t2 ( 2 ) :367-376.
  • 2Ose L F,-Joan A G, Dominick J A. Platelet abnormalities in diabe- tes mellitus [ J ]. Diabetes Vase Dis Res, 2010,7 (4) :251-259.
  • 3Tschoepe D,Roesen P ,Schwippert B,et al. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis [J]. Semin Thromb Hemost, 1993,19 ( 2 ) : 122-128.
  • 4Angiolillo D J. Antiplatelet therapy in dlabetes:efficacy and limi- tations of current treatment strategies and future directions[ J]. Di- abetes Care ,2009,32 ( 4) :531-540.
  • 5Scognamiglio R,Avogaro A,De Kreutzenberg S V,et al. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocrdial dysfuntion in type 2 diabetes [ J ]. Diabetes, 2002,51 (3) :808-812.
  • 6Wu G Z,Hong G,Zhang W P,et al. Effect of 1-[4-[-2(4-Bromo- benzene- sulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methyl- cyclohexyl) urea( 14 ), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro [ J ]. Rzneimittelforschung, 2009,59( 11 ) :550-556.
  • 7Nakahata N. Thromboxane A2 : Physiology/pathophysiology, cellu- lar signal transduction and pharmacology [J]. Pharmacol Ther, 2008,118(1 ) :18-35.
  • 8Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications [J]. Curr Di- abetes Rev ,2005,1 ( 1 ) :95-106.
  • 9Ferreiro J L, G6mez-Hospita1.1 A, Angiolillo D J. Platelet abnormal- ities in diabetes mellitus [J]. Diab Vasc Dis Res, 2010,7 ( 4 ) : 251-259.
  • 10Alexandru N, Jardin I, Popov D, et at. Effect of homocysteine on calcium mobilisation and platelet function in type 2 diabetes melli- tus[J]. J Cell Mol Med, 2008,12(5B):2015-2026.

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部